⏳ Fetching live dividend data...
Home › Calculator › IVRO Dividend Calculator 2026
InVitro International · OTC
Price: $0.09 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IVRO → $11022932677517956.00M in 10 years · $914,422,088,116,892,100,000.00/month
InVitro International develops test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and Corrositex, an invitro test that determines chemical corrosivity. The company also provides customized technology services for Irritection Assay System installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements. Its products are principally used by the manufacturers of surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials. The company was founded in 1985 and is headquartered in Placentia, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open IVRO position with:
Real after-tax yield depends on where you live and how you hold IVRO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2247.19% | 2244.39% | $224,719 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1910.11% | 1907.31% | $191,011 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1797.75% | 1794.95% | $179,775 / yr |
| 🇬🇧 UK ISA | 0% | 2247.19% | 2244.39% | $224,719 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2050.56% | 2047.76% | $205,056 / yr |
| 🇨🇦 TFSA | 0% | 2247.19% | 2244.39% | $224,719 / yr |
| 🇨🇦 CA Taxable | 25% | 1685.39% | 1682.59% | $168,539 / yr |
| 🇦🇺 Super (pension) | 15% | 1910.11% | 1907.31% | $191,011 / yr |
| 🇦🇺 AU Taxable | 30% | 1573.03% | 1570.23% | $157,303 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1654.49% | 1651.69% | $165,449 / yr |
| 🇫🇷 FR Taxable | 30% | 1573.03% | 1570.23% | $157,303 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IVRO pays quarterly — 4 times per year. Next ex-div: TBD.
How IVRO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IVRO sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IVRO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →